Trial Profile
An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) Exhibiting Significant Deterioration While Taking Zidovudine (Retrovir)
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 08 Jun 2009
Price :
$35
*
At a glance
- Drugs Didanosine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 02 Nov 1999 New trial record.